About OSPRI
Advancing multiplex qPCR reagent science for laboratory research applications worldwide.
Our Mission
Advancing qPCR reagent science.
OSPRI develops multiplex qPCR reagent kits for laboratory research applications. Our vertically integrated R&D and manufacturing capabilities enable us to design, produce, and deliver high-quality reagent formulations spanning 120+ configurations across a broad range of research areas — from respiratory and gastrointestinal pathogen research to antimicrobial resistance marker investigation.
Our team unites Ph.D. scientists, molecular biologists, and seasoned R&D leaders who have collectively developed hundreds of qPCR assay formulations. This depth of expertise in primer-probe design, multiplex optimization, and extraction-free reagent chemistry allows us to deliver reagent kits engineered for research efficiency, analytical rigor, and broad target coverage.
Leadership
The Minds Behindthe Mission.
Steve M. Sorey
Co-Founder, OSPRI
Steve M. Sorey
Co-Founder, OSPRI
Executive leadership across OSPRI’s formation and growth, with a focus on building vertically integrated molecular research capabilities.
Jeremy Adamic
Co-Founder, OSPRI
Jeremy Adamic
Co-Founder, OSPRI
Co-founder guiding corporate strategy, partnerships, and commercial direction for OSPRI’s research reagent platform.
Randy Phelps
Co-Founder & Chief Operating Officer, OSPRI
Randy Phelps
Co-Founder & Chief Operating Officer, OSPRI
Operations and integration leadership spanning R&D, manufacturing scale-up, and day-to-day execution across OSPRI teams.
Dr. Alaina Vincent
Co-Founder & Chief Clinical Director, OSPRI
Dr. Alaina Vincent
Co-Founder & Chief Clinical Director, OSPRI
Clinical and scientific program leadership shaping assay design priorities and research-facing product strategy.
Dr. Rob E. Carpenter, PhD, MBA
Co-Founder, OSPRI & Chief Scientific Strategy Officer
Dr. Rob E. Carpenter, PhD, MBA
Co-Founder, OSPRI & Chief Scientific Strategy Officer
Research strategy and external scientific engagement, including publication-driven evidence generation and technical roadmap alignment.
Kerrigan Keele, MS, MBA
Vice President, Strategic Operations
Kerrigan Keele, MS, MBA
Vice President, Strategic Operations
Strategic operations and program execution supporting scale, cross-functional alignment, and R&D operational effectiveness.
Research & Development Team
Ricardo Petroni, PhD
Kabita Pandey, PhD
Salima Karki
Production Team
Fatemeh Nouri, PhD, Regulatory Science (UAMS)
Brandon Kubala, BS, CG(ASCP)CM
Katelyn Kyser, BS, MHA
Daymon Hail, MS
Kenia Delgado
Catherine Barton, BS
Ramiro Fernandez, BS
Krishna Mohana Avva, MS, Bioinformatics (NEU)
Jessica Thompson, BS Biochem, BS Chem
Corbin Miller
Our Approach
Research-driven reagent innovation.
Optimized Research Workflows
We design reagent formulations that simplify protocols and reduce consumable burden, enabling researchers to focus on discovery rather than sample preparation.
Rigorous Analytical Design
Each reagent kit is built with multiplex architecture, optimized primer-probe chemistry, and integrated controls to support high-confidence research data generation.
Built for Evolving Research Needs
With rapid innovation cycles and a broad target library spanning bacteria, viruses, fungi, parasites, and antimicrobial resistance markers, OSPRI adapts to evolving research objectives.